Logo

Abbott and Dharmacon Announce siRNA Collaboration

Jul 29, 2003

NEW YORK, July 29  -- Abbott Laboratories and Dharmacon, of Lafayette, Colo.,  today announced a collaboration to develop a library of short-interfering RNA (siRNA) covering 4,000 genes to identify potential drug targets for therapeutics.

 

Financial details were not disclosed.

 

The siRNA library will be used in functional genomic studies designed to identify and validate drug targets for therapeutics for cancer, diabetes, pain management, inflammation, and neurological disorders.

Breaking News
The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.